The company raised more than 70 million USD in venture capital before largely collapsing around 2012 with a failed public offering, the exit of senior executives, the shutdown of manufacturing, and the cessation of most research activities.[3]
Avesthagen later undertook research and development initiatives that include The 10,000 Avestagenome Project[4][5] which led to the sequencing the first complete Zoroastrian-Parsi mitochondrial reference genome and genetic signatures of an endogamous non-smoking population with the hope of identifying disease specific markers in the space of cancers, neurodegenerative diseases and rare diseases.
Morawala-Patell founded Avesthagen Limited in 1998. The company raised more than 70 million USD in venture capital and had more than 650 employees. The company was unable to commercialize its patents and intellectual property leading to a revenue crisis around 2012.
Awards
2005
The GR8! Women Award for Science & Technology by the Indian Television Academy[6]
Recognised by the Adolfo Ibanez University for Achievements in Innovation and Creation of Value. Award was conferred upon her at the opening of VentureL@b by President of Chile, Michelle Bachelet[10][11]
2009
Karmaveer Puraskar award as a Corporate Citizen for her contribution in the field of agriculture and healthcare in by iCONGO for Citizen Action and Social Justice.[12]
Morawala-Patell received the prestigious the Businesswoman of the Year Award 2010 for business excellence at Satya Brahma founded Pharmaleaders 3rd Annual Pharmaceutical Leadership Summit 2010 in Mumbai.[13]